Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of immune response to MenBvac in children from Dieppe
2007-000298-49Phase 3Active
- Sponsor
- Rouen University Hospital
- Start
- Jan 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of MenBvac in meningococcal disease, sponsored by Rouen University Hospital. Primary endpoint: Serum bactericidal activity titer against Neisseria meningitidis clone B:14,P1-7,16. Started Jan 2007; status: active.
02
Drugs
MenBvac
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on 2007-000298-49.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000298-49.